-
PerkinElmer Reports EPS of $0.34 vs. $0.31 Estimate; Revenues $447.9M vs. $424.65M Estimate (PKI)
Thursday, May 5, 2011 - 4:23pm | 21PerkinElmer (NYSE: PKI) Reports EPS of $0.34 vs. $0.31 Estimate; Revenues $447.9M vs. $424.65M Estimate
-
Bulls Betting on Affymetrix, Inc. (AFFX)
Thursday, May 5, 2011 - 3:09pm | 130Shares of Affymetrix, Inc. (NASDAQ: AFFX) are higher on the session by 3.36%, currently trading at $5.84. The stock has been moving largely higher over the past five months and is currently trading above the 50-day and 200-day moving averages. Options traders are buying calls on the name today. A...
-
Hearing FDA Approval In AMAG Pharma For Brain Tumors (AMAG)
Thursday, May 5, 2011 - 12:57pm | 32Hearing FDA Approval In AMAG Pharma (NASDAQ: AMAG) For Brain Tumors http://www.accessdata.fda.gov/scripts/opdlisting/oopd/OOPD_Results_2.cfm?Index_Number=338411
-
Benzinga's Volume Movers (KNDL, NVLS, QNST, TRMB)
Thursday, May 5, 2011 - 10:24am | 163Kendle International Inc (NASDAQ: KNDL) shares moved up 57.84% to $14.99 at 10:20 am. The volume of KNDL shares traded was 7180% higher than normal. INC Research LLC announced its plans to acquire Kendle for around $232 million in cash. Novellus Systems Inc (NASDAQ: NVLS) shares rose 7.65% to $35....
-
Morning Market Movers (KNDL, EONC, ZSTN, CRU)
Thursday, May 5, 2011 - 9:49am | 132Kendle International Inc (NASDAQ: KNDL) jumped 57.79% to $14.99 at 9:45 am. INC Research LLC announced its plans to acquire Kendle for around $232 million in cash. eOn Communications Corporation (NASDAQ: EONC) shares advanced 25.17% to $1.79. EONC shares have dropped 40.17% over the past 52 weeks...
-
Jefferies Raises PT On Charles River Laboratories To $44
Thursday, May 5, 2011 - 9:05am | 28Jefferies & Company has raised the price target on Charles River Laboratories (NYSE: CRL) from $40 to $44 and maintains its Hold rating.
-
Jefferies Comments On Albany Molecular Rsrch Growth Focus
Thursday, May 5, 2011 - 8:51am | 84According to Jefferies, Albany Molecular Rsrch (NASDAQ: AMRI) continues to focus on growth opportunities outside the U.S. while recapturing business at home. Jefferies said that Allegra royalties got a significant boost but not enough to produce a profitable quarter. “Issues surrounding the...
-
Jefferies Comments On INC Research Offer To Kendle
Thursday, May 5, 2011 - 8:37am | 87According to Jefferies, Kendle Int'l (NASDAQ: KNDL) were made an all-cash acquisition offer by INC Research. Jefferies said that INC Research (private) made a $15.25 per share all cash offer for Kendle, representing a 60.5% premium over yesterday's close. “The purchase price implies a 9.2x...
-
Benzinga's Top Pre-Market NASDAQ Gainers (KNDL, HNSN, JDSU, ONNN)
Thursday, May 5, 2011 - 8:16am | 140Kendle International Inc (NASDAQ: KNDL) shares surged 58.42% to $15.05 in the pre-market session. INC Research LLC announced its plans to acquire Kendle for around $232 million in cash. Hansen Medical Inc (NASDAQ: HNSN) shares advanced 11.11% to $3.40 in the pre-market session. HNSN reported a 95...
-
Response Genetics, Inc. Announces $2.3 Million Equity Financing (RGDX)
Thursday, May 5, 2011 - 8:00am | 76Response Genetics, Inc. (Nasdaq: RGDX) announced today that it has agreed to sell 1,175,512 shares of its common stock, at a price of $1.99 per share in a registered direct public offering to certain institutional investors. Response Genetics, Inc. expects to receive net proceeds of approximately $...
-
Top 4 Mid-Cap Stocks In The Scientific & Technical Instruments Industry With The Highest Cash (GRMN, WAT, BIO, BEC)
Thursday, May 5, 2011 - 12:31am | 133Below are the top mid-cap scientific & technical instruments stocks on the NYSE and the NASDAQ in terms of cash. Garmin Ltd (NASDAQ: GRMN) had $1.29 billion in total cash and no debt for the latest quarter. Waters Corporation (NYSE: WAT) had $1.04 billion in total cash and $790.35 million in...
-
Covance Reports EPS of $0.54 vs. $0.58 Estimate; Revenues $502M vs. $496M Estimate (CVD)
Wednesday, May 4, 2011 - 4:06pm | 21Covance (NYSE: CVD) Reports EPS of $0.54 vs. $0.58 Estimate; Revenues $502M vs. $496M Estimate
-
Options Brief: Thermo Fisher Scientific Inc. (TMO)
Wednesday, May 4, 2011 - 11:44am | 80Shares of Thermo Fisher Scientific Inc. (NYSE: TMO) are lower on the session by 0.68%, trading at $60.23. Overall put volume is now running at 2.26x the daily average, with 65% of all puts traded being purchases on the offer. 1,073 contracts have traded on the session so far. Thermo Fisher...
-
UPDATE: Jefferies Color On BIO Target Increase
Wednesday, May 4, 2011 - 9:20am | 89Jefferies, which raised its PT on shares of Bio-Rad Laboratories, Inc. (NYSE: BIO), is providing some color on the stock. “BIO's adjusted 1Q11 EPS of $1.26 was $0.06 below consensus as a higher tax rate and below the line items offset a better than expected revenue growth experience,” Jefferies...
-
J.P. Morgan Downgrades AMAG To Neutral
Wednesday, May 4, 2011 - 9:13am | 223According to J.P. Morgan, AMAG Pharmaceuticals (NASDAQ: AMAG) reported a 1Q loss per share of ($1.05) versus consensus of ($0.99) and the estimate of ($1.04). J.P. Morgan said that the downside was driven by lower Feraheme sales of $10.9M (JPMe: $14.4M; cons: $14M), partially offset by lower opex...